Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 12 Schemes (10.65%)
Foreign Institutions
Held by 9 Foreign Institutions (0.72%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
11 Million
(Quarterly Results - Sep 2025)
Net Profit:
10 Million
Pharmaceuticals & Biotechnology
USD 208 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-4.76
-999,999.00%
-70.96






